Blood Pressure Drug Recall

The FDA has announced that a specific lot of blood pressure medication has been recalled after a bottle from was found to be mislabeled.

The bottle was supposed to contain Hydrochlorothiazide Tablets USP 12.5 mg, but instead, they contained Spironolactone Tablets USP 25 mg.

Spironolactone is used to treat congestive heart failure and the FDA noted that the effects of mixing up the medications can range from "limited" to "life-threatening."

The lot number is PW05264.